In a previous study (1) of the greatly increased gonadotropic effect of prolan when it is combined with some component of the anterior hypophysis, it was pointed out that the hypophyseal substance in question could be neither the growth nor gonad-stimulating hormone. Indeed, at that time it seemed that this substance had no physiological effect of its own, but was dependent upon its combination with prolan for the exhibition of activity. It can now be shown that the substance (the so called synergic factor) exhibits peculiar gonadotropic effects which distinguish it from any substance hitherto isolated from the hypophysis. When it is administered alone (i.e. uncombined with prolan) in three daily injections with autopsy of the animals at the end of 96 hours, it has produced little or no enlargement of the ovaries; yet sacrifice of the experimental animals at 36, 60 and 84 hours (Chart 1) shows that definite gonadotropic properties are possessed by this material, evidenced by slightly increased ovary weights as early as the 36th hour after the beginning of dosage, an effect earlier than that secured by some of the most potent gonadotropic preparations known. For example, the remarkable gonad-stimulating hormone from pregnant mare's serum produces a slower initial development of the ovary, which increases rapidly after about 72 hours so that the maximum effect from three daily doses is produced in 96-120 hours. Prolan is similar in its insignificant early effect on the ovary but the ovary weights plateau after 72 hours. These types of ovarian development are shown graphically in Chart 2 (a) and the comparison of prolau, Hou~,.~ CHART 1. Early response of the ovary to the synergistic factor followed by regression within 96-120 hours. The preparations indicated have been subjected to different treatments:
Glacial acetic acid (R3521). ........ Isoelectric precipitation (supernatant) (R3523).
Trypsin and erepsin digestion (R3522).
synergic factor, synergic factor in combination with prolan, and pregnant mare's serum may be made. When the injections are continued for a total of 6 days (instead of the usual three day injections with autopsy at 96 hours) the deve]opmerit produced in the ovaries by the synergic factor does not regress but is maintained. Chart 2 (b) shows the ovarian weights produced by this method of injection using the same gonad-stimulating substances as before. In the cases where the synergic substance was injected for 6 days (twice daily, as in Chart 2 (a)), the ovary weights do not decrease after 72-84 hours as in the case of the three injections.
The increased ovary weights are at first not paralleled by clear morphological expression. Even though increase in ovarian weight is noted before 36 hours, the ovary may show only a slightly increased vascularity. An increase in the number of medium sized follicles is, however, usually noted by 24-48 hours. Some ovaries show no further development even by 113 hours. This is true for example of the synergic fraction prepared by trypsin and erepsin digestion (R3522) shown in Chart 1. However, the ovaries of animals injected with the synergic factor more frequently show by 40-84 hours at least a few intermediate bodies or small and medium corpora. Ovulation has never been noted. Uterine development, vascularization and increase in size, is often observed by 24-48 hours.
Non-Identity of the Synergic Factor with Other ttypophyseal Substances
In 1931 Fevold, Hisaw and Leonard of Wisconsin (2) reported the fractionation of pyridine extracts of the entire hypophysis into follicle-stimulating and luteinizing components, the latter fraction without detectable action on the ovary when administered alone; but when combined with the former, it increased markedly its action. Indeed, the whole efficacy of unfractionated pyridine extracts was again secured by recombination of the two fractions. The recombination phenomenon resembles so strikingly what we have described as the activation phenomenon resulting from the addition of prolan to some hypophyseal substance, that an examination of the two procedures for possible underlying identity is important. Furthermore, Leonard (3) has shown that the follicle-stimulating fraction of Fevold, Hisaw and Leonard (2) gave augmentation when combined with prolan. Hisaw and his collaborators have also pointed out (4) that prolan and their luteinizing fraction behave similarly in augmenting the action of the follicle-stimulating fraction. In comparing the properties of the hypophyseal synergic factor prepared in this laboratory with the properties ascribed to the follicle-stimulating fraction (2, 5) several differences became apparent. Firstly, the synergic factor given in increasing doses, though producing definite ovarian development in 96 hours, does not give the large ovaries described for the follicle-stimulating fraction. In Table I , it is seen that a dose of the synergic principle 100 times that necessary to give activation (the minimal effective dose) produces only moderate ovarian development.
Secondly, the synergic factor which is very potent in its ability to augment the action of prolan gives only moderate ovary weights (Table II) when combined with the luteinizing fraction. However, the foUicle-stimulating fraction is augmented by both the luteinizing fraction and prolan (4), producing large ovary weight as well as high percentage activation.
Most fractions of the synergic factor so far obtained give some luteinization of the ovaries in 96 hours although uniform enlargement of the follicles to medium sized structures is the chief effect. Whether the luteinization is an inherent property of the substance, is due to contamination by the luteinizing fraction or is due to the animal's own hypophysis cannot be said at present.
These facts clearly indicate that the synergic factor, prepared in this laboratory, cannot be identified with either the luteinizing or folliclestimulating fractions and is actually a third gonadotropic substance from the pituitary. Indeed, it would appear that the follicle-stimulating fraction (2, 5) is a mixture of the synergic factor herein described, with what has been designated as the follicle-stimulating substance. There is no question as to the non-identity of prolan and the luteinizing fraction.
It would appear, then, that we are not justified in identifying the above mentioned recombination effects with our activation experiments, that indeed a comparison of the two experiences cannot as yet be instituted, although future research may disclose an underlying reason why the combinations in question should necessarily increase in each instance the gonadotropic effect.
Antagonism of Gonad-Stimulating Effects by Some Hypophyseal Component
Some years ago it was shown that the normal gonad-stimulating effect of implants of anterior hypophysis in hypophysectomized rats (Smith (6)) or normal immature rats (Evans and Simpson (7)) could be prevented by the simultaneous intraperitoneal injection of crude extracts of anterior hypophysis. Leonard (8) has shown similarly that simultaneous injection of Van Dyke's growth extract effectively masked the action of the follicle-stimulating fraction.
It may be noted here that the conditions employed for obtaining synergism are by subcutaneous injection of the in vitro combination of prolan with the synergic factor. The conditions used for demonstration of the antagonism phenomenon were subcutaneous injection of pro]an and simultaneous intraperitoneal injection of the hypophyseal component.
In this investigation, the capacity of fractions containing the synergic factor to decrease the action of potent gonad-stimulators was determined and this property was almost invariably a concomitant of the synergistic activity (Table III) . However, when digestion of anterior lobe was carried out (digestion with trypsin followed by a short digestion with erepsin) the two activities were differentially separated. The synergic factor was not injured but the digested ma-terial was no longer able to influence adversely the gonadotropic effect of prolan. Similarly an isoelectric precipitation at pH 4.4-4.6 of Table III ) strongly indicate that the two properties are not due to the same constituent. The fact that these fractions contain little or no growth hormone and do not contain the luteinizing or follicle-stimulating fractions would seem to eliminate the synergic material and these other substances from consideration as the antagonist. 
Optimal Conditions for the Demonstration of Synergism
It seemed of interest to determine the effect of prolan variously prepared on the degree of synergism obtained. In this respect, prolan prepared by the alcohol-ammonia extraction method (9) was found to be much more potent than that prepared by repeated alcohol precipitation (see Table IV ).
In order to determine the optimal proportions of prolan and the synergic factor, a constant amount of prolan was used in combina-tion with varying amounts of the synergic principle and a constant amount of the synergic principle was used in combination with varying amounts of prolan. The results are given in Tables I and V . It is seen that for optimal augmentation between 10 and 20 times the minimal dose of prolan (gonadotropic assay) is necessary in combination with about two to three times the minimum dose of the synergic factor (activation assay). The use of larger doses of the synergic factor is inadvisable, since the augmentation produced is not as great as that given by the lower doses. This may possibly be due to the presence of the antagonistic substance (vide supra) as a contaminant in the preparations then employed. As to duration of the synergic experiments, Chart 2 indicates that a sufficient augmentation (with three injections) is obtained in 72 hours which is, therefore, not too early to terminate the experiment.
Chemical Characteristics of the Synergic Factor
The comparative stability of the synergic substance noted in the previous paper (1) has been shown to extend over a wide variety of hydrogen ion concentrations, even at slightly elevated temperatures. Thus in alkaline solution pH 8-12 it was stable at room temperature for 24 hours. At pH 8.5 it was seriously injured in 1-3 hours at 70°C. but at 37°C. it was stable for 6 hours. In acid solutions (pH 4-1) it was somewhat destroyed in 24 hours at room temperature. At pH 4-5 it was quite stable for 1-5 hours at 37°C., but 9 hours at pH 2 completely inactivated the material. Stability to acid and alkali is illustrated in Tables III and VI. Enzymatic hydrolysis of anterior lobe material was next undertaken in order to remove as far as possible protein contaminants without destruction of the synergic principle. Pepsin was found to be unsatisfactory since the synergic factor was readily injured. Trypsin, however, was found to be quite advantageous since 4-5 hours digestion at 37°C. hydrolyzed a considerable portion of the protein, but did not affect the activity of the synergic principle. When the tryptic digestion was followed by erepsin, though some further hydrolysis was effected, there was little loss in activity. The erepsin digestion was of value since the antagonistic factor was thereby eliminated. The action of various digests is shown in Table VI .
Following tryptic and ereptic digestion, the solution could be concentrated in vacuo to one-tenth the original volume and then the addition of alcohol to a concentration of 80 per cent precipitated the active material which was potent for synergism in 0.27 rag. dose (3700 rat units per gin.). This material gave a positive biuret test.
The most convenient method of preparing a potent fraction of the synergic principle is the aqueous alcohol extraction procedure previ-ously described (1) . The material, however, contained appreciable amounts of the antagonistic factor among other possible contaminants.
Isoelectric precipitation of impurities was efficacious both in the elimination of the antagonistic factor and in producing the most potent 205 fraction yet obtained. A potent fraction of the synergic factor (containing 7300 rat units per gin.) was precipitated isoelectrically and the supernatant liquor contained the active material which was precipitable by alcohol. This material was potent in a total dose of 27 gamma (37,000 rat units per gm.). It still gave a biuret test. The biological assay of the active fractions described above (from digestion and from isoelectric precipitation) is shown in Table VII . 
Biological Procedures
Unless otherwise specified experimental groups consisted of three female rats, 22-26 days of age at the beginning of the experiment. Daily injections were made on 3 consecutive days.
Standardization of gonadotropic substances was always made by subcutaneous injection. When testing for synergism the in vitro mixture of the two components was likewise injected subcutaneously. The desired amounts of prolan and synergic factor were dissolved in a total of 11 cc. of water; each rat received a total of 3 cc. of the mixture. Parallel tests were always made with each component of this mixture; each substance was dissolved in 11 cc. of water so that the total volume of liquid administered in control experiments and in the synergism experiments was the same. In order to demonstrate antagonism, the hypophyseal fraction was always administered intraperitonea]ly, and the prolan was simultaneously injected subcutaneously. Each component was dissolved in 5.5 cc. of water, with daffy injec-tion of 0.5 cc. of each solution per rat. In the control experiments each of the components used in combination was dissolved in 11 cc. of water and 1 cc. was iniected daily. As in the combination experiment the prolan was injected subcutaneously and the hypophyseal component intraperitoneally.
All experimental animals were sacrificed 96 hours after the first injection unless otherwise specified. The ovaries were observed under a binocular microscope, then carefully dissected and weighed. The weights of ovaries given in the tables are averages based on three animals.
Preparation of Fractions Potent in the Synergic Substance
The aqueous alcohol extraction method previously described (1) has been found to be the most satisfactory method of preparing comparatively potent fractions of the synergic principle. Frozen sheep anterior pituitary glands (1370 gin.) were ground very fine into 5000 cc. of 60 per cent alcohol. The mixture was allowed to stand for 6 hours at room temperature with occasional stirring after which the solvent was decanted and filtered and the fluid saved (ca. 4500 cc.). The gland residue was reextracted with 5000 cc. of 40 per cent alcohol for 15 hours. The solvent was again decanted (ca. 4500 cc.) and the extraction repeated with 5000 cc. of 40 per cent alcohol for 3 hours. The combined filtrates (14,000 cc.) were poured into 32,000 cc. of alcohol and a small amount of saturated alcoholic sodium acetate was added to precipitate the active material. By this means there was obtained 6.0 gin. of a powder, almost completely soluble in water and potent in 0.136 rag. dose (R3372 , Table VII ).
Isoelectric precipitation of the above product eliminated inactive material and other impurities. For this procedure 1 gm. of the substance was dissolved in 100 cc. water and the insoluble material centrifuged off. The solution was adjusted to pH 4.4 and a large proportion of the material then precipitated. The mixture was allowed to stand 8 hours at room temperature and the precipitate was centrifuged off. Most of the activity was retained by the supernatant liquor which was poured into 500 cc. of alcohol and the active material precipitated by the addition of a small amount of saturated alcoholic sodium acetate. The yield was 0.16 gin. of a powder, potent in 0.027 mg. dose (R3500 , Table VII ) and giving a positive biuret test.
For the study of the action of enzymes on the anterior pituitary, with particuiar reference to the synergic and antagonistic principles, an alkaline extract of anterior lobe was used as stock material. Desiccated sheep anterior hypophysis (20 gm.) was extracted thoroughly with 1000 cc. of dilute sodium hydroxide solution (pH ca. [8] [9] and the insoluble material centrifuged off (the yield of the insoluble fraction was 10.5 gin. and contained little of the synergic factor). The alkaline solution was adjusted to neutrality and used as the starting point for the following digestions. It contained about 1 per cent of the anterior lobe material.
The digestions with trypsin were carried out by adding 1 part of trypsin (Fairchild Bros. and Foster) to 100 parts of anterior lobe. The solutions were adjusted to pH 8.5 and kept at 37°C. throughout the digestion. The progress of the digestion was followed by determining the change in total acidity (10, ll) . Aliquots of the solution were titrated at intervals with sodium hydroxide solution using thymolphthalein as the indicator. Digestion was found to be practically complete in 4 to 5 hours. Since no foreign buffer was used to maintain the hydrogen ion concentration, the solution was readjusted to pH 8.5 every 2 hours. The tryptic hydrolysis did not affect the synergic principle but digested much of the inactive protein present in the solution (Table VI) .
Anterior lobe solution digested with trypsin was then subjected to digestion with erepsin. Erepsin (The Arlington Chemical Co.) was added in an amount equal to 1 per cent of the original concentration of anterior lobe, the solution adjusted to pH 8.0 and kept at 37°C. during the digestion. There was little change in titratable acidity during 4 hours but biological assay of the resulting solution indicated that the antagonistic factor had been destroyed with little harm to the synergistic principle (Tables III and VI) .
Pepsin digestion of the alkaline extract of anterior lobe was carried out using 1 part of pepsin (The Wilson Laboratories) to 100 parts of anterior lobe material. Digestion at pH 4.0 and 37°C. completely destroyed the activity of the synergic principle within 4.5 hours (Table VI) .
Solutions of the anterior hypophysis digested with trypsin and erepsin as described above gave no precipitate on addition of alcohol to 80 per cent concentration. The solutions were, therefore, first concentrated in vacuo (at a water bath temperature of 55°C.) to one-tenth the original volume. This concentrate on precipitation with four volumes of alcohol gave a product which was easily soluble in water and contained most of the activity present in the original solution. It was potent in 0.136 rag. dose and gave a positive biuret test.
SUM-MARY
The hypophyseal substance--the synergic factor--which gives increased gonadotropic effects when combined with prolan has been shown to itself possess a definite though slight gonadotropic activity. It produces transitory follicular enlargement within 24-48 hours, which, however, regresses at once on cessation of treatment so that by the end of the 4th day the ovary again approximates its infantile weight.
The synergic principle indeed provokes only moderate ovarian development when administered in 100 times the dose necessary to demonstrate the activation phenomenon.
By means of isoelectric precipitation or by means of tryptic and ereptic digestion, fractions containing the synergic principle were freed of many contaminants, in particular of the antagonistic factor.
The synergic principle has been shown to be unaffected by digestion
